$AMRZ

Earnings call transcript: Amrize misses Q2 EPS view as shares drop 8.4% on margins

Amrize reported Q2 adjusted EPS of $0.713, below the $0.758 analyst estimate, while revenue rose to $2.83 billion versus $2.67 billion expected, according to the company. Inflation pressure weighed on margins and shares fell 8.44% to $38.28 after hours. Full-year 2026 revenue guidance was raised to $12.5-$12.7 billion and adjusted EBITDA to $3.1-$3.2 billion.

Original reporting
Published Aug 7, 2026, 4:36 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 1:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AMRZ
Bearish
medium confidence
Mentioned
$AMRZ
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$AMRZBearishMed
01

Why it matters

The market reaction was sharply negative, implying traders are prioritizing margin durability and the timing of cost recovery over top-line growth. Raised guidance may partially offset, but the article emphasizes cost inflation remaining elevated into Q3.

02

Market read

A revenue beat paired with an EPS miss and margin squeeze drove an 8.44% after-hours decline, while management raised full-year guidance and guided improving price-over-cost in 2H.

03

What to watch

Guidance includes specific pricing and volume expectations (cement flat to low single digits, aggregates mid-single digits freight-adjusted) that could reduce uncertainty if investors were over-discounting near-term inflation.

Relevance 8/10Novelty 6/10Timing: after-hours reaction to Q2 results and guidance update (Aug 7)

Background

Amrize’s Q2 results were mixed: revenue beat expectations, but adjusted EPS missed due to cost inflation and weaker price-over-cost timing.

Company-level read

Ticker impact

$AMRZBearishMedium confidence
Context

Amrize reported adjusted EPS of $0.713 vs $0.758 expected, while revenue beat, and shares fell 8.44% after-hours on margin pressure.

Expected impact

Bearish near-term bias as the market focuses on margin trajectory and price-over-cost timing into 2H.

Evidence & confidence

The article ties the stock drop directly to the EPS miss and margin concerns, while guidance is raised but still reflects inflation offset and cost pressure timing (elevated in Q3, easing in Q4).

Market effects

Signals continued margin sensitivity for building materials and construction-related supply chains to oil-linked freight and diesel/raw-material costs.

Highlights demand strength in North American mega-project markets (data centers, energy, infrastructure) but with profitability lag.

Reinforces that global commodity-linked logistics costs can quickly transmit into earnings even when volumes and pricing hold up.

Counterpoint

The company beat revenue and raised full-year guidance, suggesting the margin squeeze may be temporary as price-over-cost improves in 2H.

Key entities

  • Amrize

    Building materials and building envelope provider reporting Q2 results, EPS miss, and raised full-year revenue and adjusted EBITDA guidance.

  • Jan Jenisch

    Chairman and CEO commenting on demand strength and oil-price-driven cost inflation management.

Related articles

$AMRZMedAI 8/10

Amrize (AMRZ) Q2 2026 Earnings Call Transcript

Amrize AG (AMRZ) reported Q2 2026 revenue of $3.49B, up 8.6%, and net income of $476M, up 14.4%, with adjusted EBITDA of $986M. Management raised fiscal 2026 revenue guidance to $12.5B-$12.7B but revised adjusted EBITDA to $3.1B-$3.2B due to oil-driven cost inflation. The company cited data center and infrastructure demand.

$AMRZMedAI 8/10

Amrize Q2 EPS misses $0.94 estimate as costs weigh on margins

Amrize (NYSE: AMRZ) reported Q2 2026 adjusted EPS of $0.88, below the $0.94 consensus estimate. Revenue rose 8.51% to $3.494 billion, beating the $3.365 billion expectation. Net income increased 14.4% to $476 million. The company raised FY2026 revenue guidance to $12.5B-$12.7B but lowered adjusted EBITDA guidance to $3.1B-$3.2B due to cost inflation.

$AMRZMed

RBC Downgrades Amrize After A Rare Q2 Miss

RBC downgraded Amrize after a rare Q2 miss and reduced guidance, citing a timing mismatch between input-cost increases and the full pass-through of surcharges and price hikes. RBC cut 2026-2028 EBITDA estimates by 4%, 6%, and 7% and EPS by 12%, 14%, and 15%, lowering its stock rating to underperform and price target to $48 from $60.

$AMRZMedAI 8/10

Amrize Q2 Earnings Call Highlights

Amrize (AMRZ) reported Q2 revenue up 8.6% and adjusted EBITDA up 5.8% to $986 million, with net income up 14.4%, citing demand across data centers, energy and infrastructure. Higher freight, diesel and raw-material costs pressured margins. The company raised 2026 guidance: revenue $12.5B-$12.7B and adjusted EBITDA $3.1B-$3.2B, citing pricing lag and inflation.